Articles from Chain Drug Review (May 13, 2024)

1-36 out of 36 article(s)

Title	Author	Words
AAM: Put generics on lower Part D formulary tiers.		658
Anktiva is 'next generation' bladder cancer therapy.		1174
APhA recommends shields against system breaches.		297
Aurigene, Vipergen partner to accelerate drug discovery.		543
B+L recycling making positive impact.		279
Campaign for Seinfeld's Unfrosted promotes Pop-Tarts.		332
Coming to your Walgreens pharmacy: clinical trials.		479
CONSUMABLES SALES IN DRUG STORES BY CATEGORY.		639
Consumer value must be the focus.		618
Dr Scholl's partners with Douglas to promote foot care.		457
Edeker is Fantle Award recipient.		359
Evernorth biosimilar has zero out-of-pocket cost.		360
FDA clears high-concentration biosimilar Cyltezo.		419
Food is Medicine's place at pharmacies.	Yocky, Karen; Wing, Rodey	1624
FTC issues 'junk patent' warnings to drug makers.		702
Gallo broadens lineup with first super premium gin.		366
Host: Continue to foster 'never-ending innovations'.		806
Improvement seen coming as chains shutter weak stores.		907
Industry leaders get together.		160
Kenvue breaks ground on new headquarters.		308
KISS debuts 'easiest' Manicure & Pedicure Collection.		283
Medical costs dampen CVS' first quarter sales and profits.		563
More notable categories selected by the editors of CDR.		684
Noteworthy Categories selected by the editors of CDR.		677
Nourishing Change is set for July.		346
Nutrition industry veteran Parris succeeds Toll as lovate CEO.		179
Pharmacists can help reverse colon cancer's trajectory.	Massey, Drew	259
PLMA show will highlight empowerment of retailers.		425
Pneumococcal vaccine trial generates positive data.		465
Private label items take share.		937
Rebound is hoped for in 2024.		869
Rite Aid offering hepatitis education.		180
Specialty Rx offerings are broadened by Walgreens.		572
The lessons of Walmart Health's closure.	Woldt, Jeffrey	704
UnitedHealth slammed for failing 'cybersecurity 101'.		807
Walmart shuttering health centers.		274